INS and Alzheimer disease: Insulin dysregulation can be characterized by low ratios of tyrosine phosphorylated insulin receptor substrate 1 (IRS1) to serine phosphorylated IRS1 [67, 68] and has been correlated with greater brain atrophy in humans with AD [55].